Comments on: A Clinical Cure for Blindness Using Stem Cells http://singularityhub.com/2009/05/19/a-clinical-cure-for-blindness-using-stem-cells/ The Future Is Here Today...Robotics, Genetics, AI, Longevity, The Brain... Fri, 10 Feb 2012 06:22:25 +0000 hourly 1 http://wordpress.org/?v=3.1.4 By: Bassie http://singularityhub.com/2009/05/19/a-clinical-cure-for-blindness-using-stem-cells/#comment-39890 Bassie Tue, 11 Jan 2011 11:02:00 +0000 http://singularityhub.com/?p=3591#comment-39890 Well there are 100 trillion cells in the body and they all communicate with each other to produce our miracle existance. Sure not even embryonic stem cells will be the ANSWER to diseased states in humans and sure they publish untruths or stretch the TRUTH of their human trials...but what other HOPE is there for people ? MONEY is the evil of this experimentation and big companies and Governments are waiting more anxiously than most. Would you prefer to wait for microscopic lenses with pixels and learning to SEE again.?. Well there are 100 trillion cells in the body and they all communicate with each other to produce our miracle existance. Sure not even embryonic stem cells will be the ANSWER to diseased states in humans and sure they publish untruths or stretch the TRUTH of their human trials…but what other HOPE is there for people ? MONEY is the evil of this experimentation and big companies and Governments are waiting more anxiously than most.
Would you prefer to wait for microscopic lenses with pixels and learning to SEE again.?.

]]> By: Bassie http://singularityhub.com/2009/05/19/a-clinical-cure-for-blindness-using-stem-cells/#comment-39887 Bassie Tue, 11 Jan 2011 10:50:00 +0000 http://singularityhub.com/?p=3591#comment-39887 I suppose those people BORN with mutations in their DNA will have to have more stem cell sessions as thier DNA will destroy any GOOD this new stem cell technology will bring. Will it be affordable ? I suppose those people BORN with mutations in their DNA will have to have more stem cell sessions as thier DNA will destroy any GOOD this new stem cell technology will bring. Will it be affordable ?

]]> By: Giving Your Kidneys a Makeover: Stem Cells Cure Nephritis | Singularity Hub http://singularityhub.com/2009/05/19/a-clinical-cure-for-blindness-using-stem-cells/#comment-7671 Giving Your Kidneys a Makeover: Stem Cells Cure Nephritis | Singularity Hub Tue, 01 Sep 2009 15:01:52 +0000 http://singularityhub.com/?p=3591#comment-7671 [...] cell option more and more often.  There’s promising evidence that disorders from diabetes to blindness can benefit from these therapies, and we’re only just beginning to understand their [...] [...] cell option more and more often.  There’s promising evidence that disorders from diabetes to blindness can benefit from these therapies, and we’re only just beginning to understand their [...]

]]> By: Stem Cell Therapy Cures Corneal Blindness | Singularity Hub http://singularityhub.com/2009/05/19/a-clinical-cure-for-blindness-using-stem-cells/#comment-2289 Stem Cell Therapy Cures Corneal Blindness | Singularity Hub Tue, 09 Jun 2009 16:28:43 +0000 http://singularityhub.com/?p=3591#comment-2289 [...] elaborate/risky strategies to treat other causes of blindness. The most similar approach is the Pfizer-backed project that aims to cure age-related macular degeneration using embryonic stem cells. This treatment, [...] [...] elaborate/risky strategies to treat other causes of blindness. The most similar approach is the Pfizer-backed project that aims to cure age-related macular degeneration using embryonic stem cells. This treatment, [...]

]]> By: Nick http://singularityhub.com/2009/05/19/a-clinical-cure-for-blindness-using-stem-cells/#comment-1285 Nick Wed, 20 May 2009 16:58:19 +0000 http://singularityhub.com/?p=3591#comment-1285 It's both funny and sad that the country responsible for pretty much all the science in the 20th century wants to keep the 20th century technology in place and tries to shun the 21st century. And as for Advanced Cell Technology, if they had good technology, why has their stock price been on a downward slide since their IPO? Their announcement of their RPE technology resulted in... no stock activity. Considering they claim there's a $28 billion dollar market related to AMD to be captured, you'd think their technology might make their company worth more than 15 cents a share. Since they're a public company, no stock worth = little ability to borrow money to capitalize on their inventions. This London Consortium is set to complete their clinical trials in 3 years time, not start them. It's privately funded and not a for-profit business. ACT will have to turn a profit to be able to bring these technologies to market, and their current stock situation makes that look like a vanishingly small prospect. Their 52-week low on stock was 1 penny. Also, I would like to point out that ACTs own website claims they were filing for an IND LAST year. And their website still says copyright 2006. If they can't keep their quite simple website up to date, why should I trust them sticking cells in my eyes? They also mix "have completed" and "will be able to" in subsequent sentences describing their technology. To wit: "Applying appropriate controls as specified in the FDA’s cGMP regulations, ACT staff was able to produce master and working cell banks of human embryonic stem cells. In working out a controlled, compliant manufacturing methodology, an unlimited amount of RPE cells can be derived by ACT for clinical use." They say they have produced cell banks, and that an unlimited amount of RPE cells can be derived. Not have been, just "can be." Smells like hyperbole to me! It’s both funny and sad that the country responsible for pretty much all the science in the 20th century wants to keep the 20th century technology in place and tries to shun the 21st century.

And as for Advanced Cell Technology, if they had good technology, why has their stock price been on a downward slide since their IPO? Their announcement of their RPE technology resulted in… no stock activity. Considering they claim there’s a $28 billion dollar market related to AMD to be captured, you’d think their technology might make their company worth more than 15 cents a share. Since they’re a public company, no stock worth = little ability to borrow money to capitalize on their inventions.

This London Consortium is set to complete their clinical trials in 3 years time, not start them. It’s privately funded and not a for-profit business. ACT will have to turn a profit to be able to bring these technologies to market, and their current stock situation makes that look like a vanishingly small prospect. Their 52-week low on stock was 1 penny.

Also, I would like to point out that ACTs own website claims they were filing for an IND LAST year. And their website still says copyright 2006. If they can’t keep their quite simple website up to date, why should I trust them sticking cells in my eyes?

They also mix “have completed” and “will be able to” in subsequent sentences describing their technology. To wit: “Applying appropriate controls as specified in the FDA’s cGMP regulations, ACT staff was able to produce master and working cell banks of human embryonic stem cells. In working out a controlled, compliant manufacturing methodology, an unlimited amount of RPE cells can be derived by ACT for clinical use.”

They say they have produced cell banks, and that an unlimited amount of RPE cells can be derived. Not have been, just “can be.”

Smells like hyperbole to me!

]]> By: Nick http://singularityhub.com/2009/05/19/a-clinical-cure-for-blindness-using-stem-cells/#comment-31233 Nick Wed, 20 May 2009 16:58:00 +0000 http://singularityhub.com/?p=3591#comment-31233 It's both funny and sad that the country responsible for pretty much all the science in the 20th century wants to keep the 20th century technology in place and tries to shun the 21st century. And as for Advanced Cell Technology, if they had good technology, why has their stock price been on a downward slide since their IPO? Their announcement of their RPE technology resulted in... no stock activity. Considering they claim there's a $28 billion dollar market related to AMD to be captured, you'd think their technology might make their company worth more than 15 cents a share. Since they're a public company, no stock worth = little ability to borrow money to capitalize on their inventions. This London Consortium is set to complete their clinical trials in 3 years time, not start them. It's privately funded and not a for-profit business. ACT will have to turn a profit to be able to bring these technologies to market, and their current stock situation makes that look like a vanishingly small prospect. Their 52-week low on stock was 1 penny. Also, I would like to point out that ACTs own website claims they were filing for an IND LAST year. And their website still says copyright 2006. If they can't keep their quite simple website up to date, why should I trust them sticking cells in my eyes? They also mix "have completed" and "will be able to" in subsequent sentences describing their technology. To wit: "Applying appropriate controls as specified in the FDA’s cGMP regulations, ACT staff was able to produce master and working cell banks of human embryonic stem cells. In working out a controlled, compliant manufacturing methodology, an unlimited amount of RPE cells can be derived by ACT for clinical use." They say they have produced cell banks, and that an unlimited amount of RPE cells can be derived. Not have been, just "can be." Smells like hyperbole to me! It’s both funny and sad that the country responsible for pretty much all the science in the 20th century wants to keep the 20th century technology in place and tries to shun the 21st century.

And as for Advanced Cell Technology, if they had good technology, why has their stock price been on a downward slide since their IPO? Their announcement of their RPE technology resulted in… no stock activity. Considering they claim there’s a $28 billion dollar market related to AMD to be captured, you’d think their technology might make their company worth more than 15 cents a share. Since they’re a public company, no stock worth = little ability to borrow money to capitalize on their inventions.

This London Consortium is set to complete their clinical trials in 3 years time, not start them. It’s privately funded and not a for-profit business. ACT will have to turn a profit to be able to bring these technologies to market, and their current stock situation makes that look like a vanishingly small prospect. Their 52-week low on stock was 1 penny.

Also, I would like to point out that ACTs own website claims they were filing for an IND LAST year. And their website still says copyright 2006. If they can’t keep their quite simple website up to date, why should I trust them sticking cells in my eyes?

They also mix “have completed” and “will be able to” in subsequent sentences describing their technology. To wit: “Applying appropriate controls as specified in the FDA’s cGMP regulations, ACT staff was able to produce master and working cell banks of human embryonic stem cells. In working out a controlled, compliant manufacturing methodology, an unlimited amount of RPE cells can be derived by ACT for clinical use.”

They say they have produced cell banks, and that an unlimited amount of RPE cells can be derived. Not have been, just “can be.”

Smells like hyperbole to me!

]]> By: Joseph http://singularityhub.com/2009/05/19/a-clinical-cure-for-blindness-using-stem-cells/#comment-1283 Joseph Wed, 20 May 2009 16:07:48 +0000 http://singularityhub.com/?p=3591#comment-1283 Advanced Cell Technology is 2-3 years ahead in the RPE research. The London Project and Pfizer just started. You should research your topic a bit more before publishing, showing all the leading players in the game. Advanced Cell Technology is 2-3 years ahead in the RPE research.
The London Project and Pfizer just started.
You should research your topic a bit more before publishing, showing all the leading players in the game.

]]> By: Joseph http://singularityhub.com/2009/05/19/a-clinical-cure-for-blindness-using-stem-cells/#comment-31232 Joseph Wed, 20 May 2009 16:07:00 +0000 http://singularityhub.com/?p=3591#comment-31232 Advanced Cell Technology is 2-3 years ahead in the RPE research. The London Project and Pfizer just started. You should research your topic a bit more before publishing, showing all the leading players in the game. Advanced Cell Technology is 2-3 years ahead in the RPE research.
The London Project and Pfizer just started.
You should research your topic a bit more before publishing, showing all the leading players in the game.

]]> By: Anonymous http://singularityhub.com/2009/05/19/a-clinical-cure-for-blindness-using-stem-cells/#comment-1279 Anonymous Wed, 20 May 2009 07:02:51 +0000 http://singularityhub.com/?p=3591#comment-1279 Andrew, I'm not entirely sure where you are located but I might suggest looking at a company in the US; Advanced Cell Technology. They are going to file an IND with the FDA in June/July for trials in humans using RPE cells (injected into the eye). Thanks. Andrew,
I’m not entirely sure where you are located but I might suggest looking at a company in the US; Advanced Cell Technology. They are going to file an IND with the FDA in June/July for trials in humans using RPE cells (injected into the eye).

Thanks.

]]> By: Anonymous http://singularityhub.com/2009/05/19/a-clinical-cure-for-blindness-using-stem-cells/#comment-31231 Anonymous Wed, 20 May 2009 07:02:00 +0000 http://singularityhub.com/?p=3591#comment-31231 Andrew, I'm not entirely sure where you are located but I might suggest looking at a company in the US; Advanced Cell Technology. They are going to file an IND with the FDA in June/July for trials in humans using RPE cells (injected into the eye). Thanks. Andrew,
I’m not entirely sure where you are located but I might suggest looking at a company in the US; Advanced Cell Technology. They are going to file an IND with the FDA in June/July for trials in humans using RPE cells (injected into the eye).

Thanks.

]]>